Skip to Main Content
Contribute Try STAT+ Today

Weighed down by the cost of opioid litigation, the American Pain Society is considering filing for bankruptcy and a decision is expected next week.

In a May 20 letter to its members, the APS board of directors blamed financial problems that have been exacerbated by the mounting expenses associated with defending lawsuits filed by local, city, and state governments over the opioid crisis. Along with drug makers and wholesalers, the professional society was named as a defendant in many of the cases.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.